Details
Stereochemistry | ACHIRAL |
Molecular Formula | 4Fe.3O7P2 |
Molecular Weight | 745.21 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O
InChI
InChIKey=CADNYOZXMIKYPR-UHFFFAOYSA-B
InChI=1S/4Fe.3H4O7P2/c;;;;3*1-8(2,3)7-9(4,5)6/h;;;;3*(H2,1,2,3)(H2,4,5,6)/q4*+3;;;/p-12
Molecular Formula | Fe |
Molecular Weight | 55.845 |
Charge | 3 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | O7P2 |
Molecular Weight | 173.9433 |
Charge | -4 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://books.google.ru/books?id=vxtxWneRBN4C&pg=PA1103v=onepage&q&f=falsehttps://mistralhowto.wordpress.com/2012/03/12/what-is-pigment-yellow-42-and-what-is-it-used-for/ | http://sensientfoodcolors.com/en-us/confection/iron-oxides-approved-by-the-fda/ | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=73.2250 | https://www.drugs.com/inactive/ferric-oxide-yellow-381.htmlhttp://www.mfc.co.jp/english/eng/product/sanferol/pdf/fls_gras_notice.pdfhttps://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000PharmR.pdfhttps://cameochemicals.noaa.gov/chemical/3468 | https://www.ncbi.nlm.nih.gov/pubmed/2135524http://www.edta-chelate.com/ferric-ammonium-edta-liquid--1640836.htmlhttps://books.google.ru/books?id=3hLmyma2-MsC&pg=PA241&lpg=PA241&dq=FERRIC+AMMONIUM+CHLORIDE retrieved from A Consumer's Dictionary of Cosmetic Ingredients, 7th Edition: Complete Information About the Harmful and Desirable Ingredients Found in Cosmetics and Cosmeceuticals By Ruth Winterhttps://www.ncbi.nlm.nih.gov/pubmed/27995746 | http://onlinelibrary.wiley.com/doi/10.1002/047084289X.rn01568/abstract?userIsAuthenticated=false&deniedAccessCustomisedMessage=Curator's Comment: description was created based on several sources, including
http://www.mfc.co.jp/english/eng/product/sanferol/index.html
Sources: https://books.google.ru/books?id=vxtxWneRBN4C&pg=PA1103v=onepage&q&f=falsehttps://mistralhowto.wordpress.com/2012/03/12/what-is-pigment-yellow-42-and-what-is-it-used-for/ | http://sensientfoodcolors.com/en-us/confection/iron-oxides-approved-by-the-fda/ | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=73.2250 | https://www.drugs.com/inactive/ferric-oxide-yellow-381.htmlhttp://www.mfc.co.jp/english/eng/product/sanferol/pdf/fls_gras_notice.pdfhttps://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000PharmR.pdfhttps://cameochemicals.noaa.gov/chemical/3468 | https://www.ncbi.nlm.nih.gov/pubmed/2135524http://www.edta-chelate.com/ferric-ammonium-edta-liquid--1640836.htmlhttps://books.google.ru/books?id=3hLmyma2-MsC&pg=PA241&lpg=PA241&dq=FERRIC+AMMONIUM+CHLORIDE retrieved from A Consumer's Dictionary of Cosmetic Ingredients, 7th Edition: Complete Information About the Harmful and Desirable Ingredients Found in Cosmetics and Cosmeceuticals By Ruth Winterhttps://www.ncbi.nlm.nih.gov/pubmed/27995746 | http://onlinelibrary.wiley.com/doi/10.1002/047084289X.rn01568/abstract?userIsAuthenticated=false&deniedAccessCustomisedMessage=
Curator's Comment: description was created based on several sources, including
http://www.mfc.co.jp/english/eng/product/sanferol/index.html
Ferric bromide, red-brown odorless compound, an oxidizing reagent, used as a catalyst for organic reactions, particularly in bromination of aromatic compounds.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0006927 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21121365 |
|||
Target ID: CHEMBL2364184 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | SANFEROL Approved UseIt has also been reported that SFC preparation improved iron deficiency in a pregnant woman with iron deficiency anemia whose hemoglobin level had not increased after administration of other iron preparations such as ferrous fumarate. A dairy supplemental dose of SFC improved iron deficiency in young women with iron deficiency. |
|||
Inactive ingredient | Oxycontin Approved UseOxyContin is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Launch Date9.0935997E11 |
|||
Curative | RADIOGARDASE Approved UseInsoluble Prussian blue is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination. Launch Date1.06496642E12 |
|||
Palliative | AURYXIA Approved UseFerric Citrate is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. Launch Date1.40978881E12 |
PubMed
Title | Date | PubMed |
---|---|---|
The formation of ferritin from apoferritin. Kinetics and mechanism of iron uptake. | 1972 Jan |
|
The absorption of iron as supplements in infant cereal and infant formulas. | 1975 May |
|
Carcinogenicity studies on natural and man-made fibres with the intraperitoneal test in rats. | 1989 |
|
Non-invasive and non-destructive micro-XRF and micro-Raman analysis of a decorative wallpaper from the beginning of the 19th century. | 2007 Feb |
|
Metal-mediated cyclization of aryl and benzyl glycidyl ethers: a complete scenario. | 2008 Dec 17 |
|
Fabrication of FeF3 Nanoflowers on CNT branches and their application to high power lithium rechargeable batteries. | 2010 Dec 7 |
|
Oxidative aromatic C-N bond formation: convenient synthesis of N-amino-3-nitrile-indoles via FeBr3-mediated intramolecular cyclization. | 2011 May 21 |
|
Finnish wallpaper pigments in the 18th-19th century: presence of KFe3(CrO4)2(OH)6 and odd pigment mixtures. | 2013 Apr |
|
FeF(3) catalyzed cascade C-C and C-N bond formation: synthesis of differentially substituted triheterocyclic benzothiazole functionalities under solvent-free condition. | 2014 May |
|
Nazarov cyclization of 1,4-pentadien-3-ols: preparation of cyclopenta[b]indoles and spiro[indene-1,4'-quinoline]s. | 2016 Feb 14 |
|
Mechanisms and origins of the switchable regioselectivity of FeBr3-catalyzed [1,2]-aryl and [1,2]-alkyl shifts of α-aryl aldehydes. | 2016 Feb 28 |
|
Superior electrochemical performance of N-doped nanocrystalline FeF(3)/C with a single-step solid-state process. | 2016 Oct 4 |
|
A Simplified Fe-Based PhotoATRP Using Only Monomers and Solvent. | 2017 Jul |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/165454
Curator's Comment: Iron oxides black, red and yellow are intended to be used as colourants in feedingstuffs for all animal species without dose or age restriction. The applicant recommends 500–1,200 mg/kg of the additives in complete (and complementary) feedingstuffs as standard dose. http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2016.4482/full
As a food supplement, ferric sodium pyrophosphate is administered orally.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 16 17:51:42 UTC 2022
by
admin
on
Fri Dec 16 17:51:42 UTC 2022
|
Record UNII |
QK8899250F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 184.1304
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1607976
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | RxNorm | ||
|
SUB13847MIG
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | |||
|
132767
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | |||
|
C82284
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | |||
|
DB09147
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | |||
|
M5327
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | Merck Index | ||
|
C45678
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
CONCEPT | Industrial Aid | ||
|
233-190-0
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | |||
|
QK8899250F
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | |||
|
Iron(III) pyrophosphate
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | |||
|
DTXSID6047600
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | |||
|
454
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | |||
|
10058-44-3
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | |||
|
C049051
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | |||
|
QK8899250F
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY | |||
|
24877
Created by
admin on Fri Dec 16 17:51:42 UTC 2022 , Edited by admin on Fri Dec 16 17:51:42 UTC 2022
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |